DRTS
NASDAQ HealthcareAlpha Tau Medical Ltd. - Ordinary Shares
Biotechnology
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
�� 市场数据
| 价格 | $13.23 |
|---|---|
| 成交量 | 282,833 |
| 市值 | 1.22B |
| 贝塔系数 | 1.220 |
| RSI（14日） | 38.9 |
| 200日均线 | $10.57 |
| 50日均线 | $14.29 |
| 52周最高 | $15.79 |
| 52周最低 | $3.43 |
| Forward P/E | -24.75 |
| Price / Book | 27.74 |
🎯 投资策略评分
DRTS 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🚀 Moon Shot (80/100) — 此策略 高增长潜力（高贝塔 + 超卖）.
评分最低的策略： 🎈 Over-Hyped (18/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 DRTS in your text
粘贴任何文章、记录或帖子 — 工具将提取 DRTS 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-10-29.